We propose in this paper to report our experiences with enterococcal endocarditis seen at the Mayo Clinic during the first decade of antibiotic therapy for bacterial endocarditis. We wish to consider particularly some of the therapeutic problems that arise in the antibiotic therapy of this valvular infection caused by penicillin-resistant streptococci.
METHODS* From January, 1944, through December, 1953, 33 cases of enterococcal endocarditis were encountered * The bacteriologic procedures in this study were performed in the Section of Bacteriology under the C(rculation, Iol'mr X, A ugust, 1954 at the Mayo Clinic. These constitute an unselected consecutive series of cases and represent approximately 10 Sirota and colleagues,49 streptomycin gave only a temporary remission. Apparently, only two of the patients included in these reports were cured with streptomycin alone.50' *' In two other cases failure with streptomycin was followed by cure with penicillin and caronamide.33' 52 The value of streptomycin in eiterococcal endocarditis lies in its supportive role to penicillin. In vitro and in vivo studies '8' 53, 4 indicate that streptomyciin synergizes the bactericidal action of penicillin so that endocarditis caused by penicillin-resistant enterococci is controlled in almost all cases. Further comments regarding the combined use of these two antibiotics will be made below.
Broad-Spectrum Antibiotics
Chlortetracycline. The value of chlortetracycline in the therapy of bacterial endocarditis has been reviewed recently by Friedberg55 and by Kane In one case (case 21) the first course of therapy was with penicillin alone. The patient did well for four months. After symptoms recurred, the in vitro sensitivity of the isolated organism was two dilutions less than that of the organism obtained initially. It would seem that the cure of this apparent reinfection was achieved by penicillin alone, since during the second course of therapy only 1 Gm. of streptomycin a day was given for 10 days together with penicillin. In the remaining three patients who had relapses, penicillin in doses of 10 to .50 million units and streptomycin in doses of 1 to 2 Gm. per day for a period of 6 to 10 weeks were needed to effect cures of these infections. Probenecid was apparently helpful ill one of these five patients (case 30).
Case Reports
Pertinent problems in the antibiotic management of enterococcal endocarditis are illustrated by the following four cases.
Case 30 . A 50 year old man was first admitted with a four-month history of low-grade fever (temperature up to 101 F.), occipital headaches, arthralgias, malaise, weakness, intermittent episodes of neck pain which extended into the right shoulder, and a 30-pound loss of weight. The onset had been sudden with headache, chill and rise in the temperature to 104 F. The positive findings were: rheumatic heart disease with an enlarged heart and aortic and mitral valvular involvement, the predominant lesion being aortic insufficiency; clubbing of the fingers; Osler's nodes; mild anemia; sedimentation rate of 108 mm. in one hour; minimal microhematuria; and three blood cultures positive for enterococci. In vitro sensitivity tests revealed the bacteriostatic end point to be 1.6 units of penicillin and more than 25 micrograms of dihydrostreptomycin. The patient was given 10 
